Featured Image
Perspectives
It is possible to produce 4th generation of drugs against CML.
Prof. Yijun Chen
China Pharmaceutical University
Read the Original
This page is a summary of: Discovery of a small molecule targeting SET-PP2A interaction to overcome BCR-ABLT315I mutation of chronic myeloid leukemia, Oncotarget, May 2015, Impact Journals, LLC,
DOI: 10.18632/oncotarget.3665.
You can read the full text:
Contributors
The following have contributed to this page
